SCHEMBL27020103

SCHEMBL27020103

COc1cc(F)c([N+](=O)[O-])cc1NC(=N)N

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HTT P42858 3/20 0.41
GAA P10253 3/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 6/20 0.40
PKM P14618 2/20 0.40
MEN1 O00255 5/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 5/20 0.39
POLB P06746 2/20 0.39
ATM Q13315 1/20 0.39
ABCB1 P08183 2/20 0.39
ABCC1 P33527 2/20 0.39
PDE5A O76074 1/20 0.39
THRB P10828 1/20 0.39
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BLM P54132 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19086066 0.87 KMT2A (0.39) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL20680892 0.83 PKM (0.45) ALDH1A1HTTLMNAKMT2APKM
SCHEMBL18038909 0.83 ALDH1A1 (0.49) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL19239593 0.80 ALDH1A1 (0.42) ALDH1A1HTTGAAKMT2APKM
SCHEMBL17059202 0.78 PKM (0.46) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL29823126 0.78 PKM (0.46) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL19254677 0.78 ABCC1 (0.39) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL28836526 0.78 ALDH1A1 (0.52) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL29025170 0.76 MAPK1 (0.41) ALDH1A1HTTGAALMNAKMT2A
SCHEMBL30063515 0.76 MAPT (0.45) ALDH1A1HTTGAAKMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119613383-A Among the octenib Synthesis method of intermediate 鲁南制药集团股份有限公司 2025-03-14 CN disclosed
CN-114874189-B Substituted heteroaryl derivatives, compositions and uses thereof 深圳市塔吉瑞生物医药有限公司 2023-09-29 CN disclosed
WO-2022166916-A1 SUBSTITUTED HETEROARYL DERIVATIVE, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2022-08-11 WO disclosed
CN-114874189-A Substituted heteroaryl derivatives, compositions and uses thereof 深圳市塔吉瑞生物医药有限公司 2022-08-09 CN disclosed
CN-109485638-B Preparation method of oxitinib intermediate 新发药业有限公司 2020-07-17 CN disclosed
CN-106366072-A Preparation method of AZD9291 上海工程技术大学 2017-02-01 CN disclosed
CN-106366022-A Intermediate used for AZD9291 preparation, and preparation method and application thereof 上海工程技术大学 2017-02-01 CN disclosed